Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded down 31.3% on Wednesday . The stock traded as low as C$0.14 and last traded at C$0.17. 1,643,425 shares were traded during mid-day trading, an increase of 205% from the average session volume of 538,457 shares. The stock had previously closed at C$0.24.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a market cap of C$23.01 million, a PE ratio of -16.50 and a beta of 0.32. The business has a 50 day moving average price of C$0.10 and a two-hundred day moving average price of C$0.07.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- What is the Euro STOXX 50 Index?
- 3 Steel Stocks Soaring After Tariff Announcements
- Do ETFs Pay Dividends? What You Need to Know
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- Investing in Construction Stocks
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
